Skip to content

    Cancer Health Center

    Font Size
    A
    A
    A

    New Hope for Breast, Prostate Cancer Testing

    'Markers' in blood, tissue might help determine best treatment for each patient, studies suggest

    WebMD News from HealthDay

    By Dennis Thompson

    HealthDay Reporter

    MONDAY, Oct. 28 (HealthDay News) -- Doctors believe they have found telltale signs that can indicate whether breast or prostate malignancies will remain dormant or develop into aggressive cancers.

    These indicators -- called "biomarkers" -- are found in the blood or tissues of people with breast or prostate cancer. Researchers hope to one day use them to develop tests that will determine the cancer treatment each patient will need.

    "It's a dream, I would say, at the moment. And it's a hope," Dr. Clifford Hudis, president of the American Society of Clinical Oncology (ASCO), said of the potential for using biomarkers to help determine a person's risk of aggressive cancer. "But it's not yet clinically validated, and it's not useful yet for patients."

    Two research teams are scheduled to present their findings on possible biomarkers for breast and prostate cancer this week at the International Conference on Frontiers in Cancer Prevention Research, hosted by the American Association for Cancer Research, at the National Harbor in Oxon Hill, Md.

    Doctors with the University of Pennsylvania reported that the presence of a protein called Vav2 in breast tissue might indicate whether a precancerous condition called ductal carcinoma in situ, or DCIS, will develop into invasive breast cancer.

    Meanwhile, Johns Hopkins researchers said chromosomes in a man's blood might provide evidence that a prostate cancer will develop in an aggressive manner.

    There is widespread concern that in both DCIS and prostate cancer, doctors tend to overtreat patients.

    Two-thirds of DCIS cases never progress to full-fledged invasive cancer, ASCO's Hudis said, "which means when we treat DCIS, we are treating many people who would never have developed invasive cancer."

    And few men with prostate cancer actually die as a result of the cancer, which has prompted much debate over whether doctors should treat it, said William Phelps, program director for the American Cancer Society. The available treatments often lead to unpleasant side effects such as incontinence and impotence.

    "The treatments themselves are not very good," Phelps said of prostate cancer. "If the treatments were fairly nondamaging, you'd just say, 'Well, let's treat everybody.'"

    1 | 2 | 3

    Today on WebMD

    Colorectal cancer cells
    New! I AM Not Cancer Facebook Group
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Ovarian cancer illustration
    Real Cancer Perspectives
     
    Jennifer Goodman Linn self-portrait
    Blog
    what is your cancer risk
    HEALTH CHECK
     
    colorectal cancer treatment advances
    Video
    breast cancer overview slideshow
    SLIDESHOW
     
    prostate cancer overview
    SLIDESHOW
    lung cancer overview slideshow
    SLIDESHOW
     
    ovarian cancer overview slideshow
    SLIDESHOW
    Actor Michael Douglas
    Article